CDC Awards $30 Million Sole-Source Cooperative Agreement to Zambia's University Teaching Hospital for HIV and TB Services
The Centers for Disease Control and Prevention (CDC) has committed an initial $30 million for Federal Fiscal Year 2026 to Zambia's University Teaching Hospital (UTH) through a sole-source cooperative agreement. This five-year funding commitment, effective September 30, 2026, aims to bolster HIV and tuberculosis (TB) clinical and laboratory service delivery across Zambia's national and provincial referral healthcare facilities. The announcement, published in the Federal Register on August 17, 2026, underscores the United States' continued strategic investment in global health initiatives, particularly in regions significantly impacted by these diseases.
The Award's Scope and Objective
The award's primary objective is to enhance the capacity of Zambia's healthcare system to manage and treat HIV and TB. Specifically, the $30 million in initial funding for FY 2026, with continuation funding anticipated for the subsequent four years, will support sustainable HIV and TB service implementation through UTH. This includes improving both clinical care and laboratory capabilities at referral-level hospitals and provincial-level referral facilities. The program seeks to ensure that patients with complex cases, such as advanced HIV disease, receive appropriate and high-quality care, thereby strengthening the overall public health infrastructure in Zambia.
Justification for a Sole-Source Agreement
A notable aspect of this award is its designation as a sole-source agreement. The CDC explicitly states that UTH is the only entity capable of performing this work. This justification rests on UTH's unique status as Zambia's national reference hospital. In this capacity, UTH is mandated to provide specialized inpatient and outpatient services for complicated medical cases, including those involving advanced HIV disease. Its central role within Zambia's healthcare hierarchy, coupled with its specific directive to handle complex infectious disease cases, positions it as the indispensable partner for a program of this magnitude and focus. This arrangement bypasses competitive bidding processes, highlighting UTH's recognized national importance and specialized capabilities.
Legal Underpinnings and Policy Context
This cooperative agreement is authorized under a series of foundational U.S. public laws that govern the nation's global health efforts. These include Public Law 108-25, known as the United States Leadership Against HIV AIDS, Tuberculosis and Malaria Act of 2003, and its reauthorization, Public Law 110-293, the Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008. Further authorization comes from Public Law 113-56, the PEPFAR Stewardship and Oversight Act of 2013, and the broader Public Health Service Act (42 U.S.C. 242I). Collectively, these statutes form the legislative backbone of the President's Emergency Plan for AIDS Relief (PEPFAR), a cornerstone of U.S. foreign policy and global health initiatives aimed at combating HIV/AIDS, TB, and malaria worldwide. The continuous referencing of these acts underscores the enduring U.S. commitment to global health security and the fight against these pandemics.
Implications for Public Health in Zambia
The implications of this substantial funding for Zambia are considerable. By targeting the national reference hospital, the CDC aims to create a ripple effect, strengthening the capacity of the entire referral system. Improved diagnostic capabilities and clinical management at UTH will not only directly benefit patients in its immediate vicinity but also serve as a training ground and a resource hub for provincial facilities. This investment is expected to lead to better patient outcomes, reduced transmission rates, and a more robust national response to HIV and TB. It represents a strategic effort to build long-term sustainability in Zambia's fight against these diseases, moving beyond emergency responses to systemic capacity building.
Broader U.S. Global Health Strategy
This award exemplifies the United States' broader global health strategy, which emphasizes partnerships with key national institutions in affected countries. By investing directly in a national reference hospital like UTH, the U.S. aims to foster local ownership and expertise, ensuring that health interventions are culturally appropriate and sustainable over time. This approach aligns with the principles of PEPFAR, which has consistently focused on strengthening health systems, building human capacity, and delivering comprehensive prevention and treatment services. The continuation of such significant funding demonstrates the U.S.'s recognition that addressing global health challenges abroad is integral to national security and humanitarian interests at home.
